Application 021393
- Type
- NDA
- Sponsor
- GLAXOSMITHKLINE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ADVIL PM | DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN | CAPSULE;ORAL | 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0573-0167 | ADVIL PM | diphenhydramine HCl, ibuprofen | Pfizer Consumer Healthcare | NDA | Current |
| 0573-0167 | ADVIL PM | diphenhydramine HCl, ibuprofen | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0573-0167 | ADVIL PM | diphenhydramine HCl, ibuprofen | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0573-0167 | ADVIL PM | diphenhydramine HCl, ibuprofen | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 79574 | SUPPL | 2024-09-10 |
| 79573 | SUPPL | 2024-09-10 |
| 69843 | SUPPL | 2022-01-12 |
| 69842 | SUPPL | 2022-01-12 |
| 54316 | SUPPL | 2018-05-23 |
| 54072 | SUPPL | 2018-05-10 |
| 47860 | SUPPL | 2017-04-05 |
| 47830 | SUPPL | 2017-04-03 |
| 36810 | SUPPL | 2013-03-22 |
| 27652 | SUPPL | 2013-03-21 |
| 5241 | SUPPL | 2011-04-21 |
| 27651 | SUPPL | 2009-05-27 |
| 27650 | SUPPL | 2008-06-16 |
| 42135 | ORIG | 2006-09-07 |
| 5240 | ORIG | 2006-01-19 |
| 15353 | ORIG | 2006-01-05 |